Table of Contents
What changed
Revenue for ordinary activities fell 92.5% to NZ$3.0k from NZ$39.5k, confirming the business is effectively pre-revenue. The reported net loss narrowed 79.5% to NZ$762.4k from NZ$3.7m, and the operating cash outflow improved 43.5% to NZ$696.1k from NZ$1.23m. Cash and cash equivalents fell 55.5% to NZ$1.11m from NZ$2.50m over the year. Total assets declined 4.1% to NZ$15.4m and equity declined 4.6% to NZ$15.2m, while total liabilities rose 66.2% off a small base to NZ$204.3k. No dividend was attributed to the period. No segment breakdown was disclosed.
What matters
- Cash runway, not earnings, is the key read. With revenue near zero, the 79.5% improvement in the loss is a cost-base movement, not a commercial inflection. At the current operating burn of NZ$696.1k per year, the NZ$1.11m cash balance implies limited funded runway absent further capital or a step-down in spend.
- The loss narrowed by more than cash burn improved. The reported loss fell NZ$2.95m, but operating cash outflow only improved by NZ$536.2k. Most of the P&L gain therefore sits in non-cash lines rather than structurally lower cash costs; the operating cash burn remains material relative to available cash.
- Equity is being eroded without offsetting top-line traction. Equity dropped NZ$739.6k while revenue collapsed, meaning the balance-sheet contraction is being absorbed without any emerging revenue engine to justify it.
Expectations
No quantified guidance, forward-work number or stated target was disclosed, so there is no management benchmark to test the result against. The shape context is weak but directional: HY21 produced only 29.7% of full-year revenue but 52.6% of the full-year loss, implying a slightly lighter cash-loss second half. The release points to a binding term sheet and completed due diligence executed in H2 plus ongoing geological targeting work, but no revenue-generating milestone, permit monetisation or production path is quantified in the extract. On the numbers supplied, the release does not support any inference of a near-term revenue ramp.
Quality of result
Low. The headline earnings improvement is dominated by the absence of the prior-year's larger non-cash items rather than any operational leverage, given revenue is immaterial. Operating cash outflow is the cleaner measure, and it remains heavily negative at NZ$696.1k. There is no EBITDA, capex or free cash flow disclosure, so cash conversion cannot be tested directly, but the fact that the P&L improvement (NZ$2.95m) is roughly 5.5x the cash-flow improvement (NZ$536.2k) indicates the reported narrowing is largely non-cash in character. ROE improving from −23.3% to −5.0% reflects a smaller loss against a still-substantial equity base, not returns on capital.
Unresolved
- What is the planned FY22 exploration spend, and is existing cash sufficient to fund it without a raise?
- What are the terms, counterparty and economic substance of the H2 "binding term sheet" referenced in the release?
- What drove the NZ$2.4m gap between the P&L improvement and the cash-flow improvement — impairment reversals, fair-value movements, or other non-cash items?
- Why did total liabilities rise 66.2% despite the wind-down in activity, and does any of that represent accrued obligations that will convert to cash outflows?
- Is there any forward-work, offtake or resource monetisation pathway that would convert the stated resource and target work into revenue?
This briefing cannot assess the geological merit of the permit portfolio, the credibility of the binding term sheet, or whether additional funding is already arranged.
Key metrics
| Metric | FY21 | FY20 | Change |
|---|---|---|---|
| Revenue | $3m | $39.5m | -92.5% ↓ |
| Net profit after tax | −$762.4m | −$3.7b | +79.5% ↑ |
| Net cash inflow from operating activities | −$696.1m | −$1.2b | +43.5% ↑ |
| Operating profit | −$760.9m | −$3.7b | +79.5% ↑ |
| Cash and cash equivalents | $1.1b | $2.5b | -55.5% ↓ |
| Total assets | $15.4b | $16.1b | -4.1% ↓ |
Analytical metrics
| Metric | FY21 | FY20 | Context |
|---|---|---|---|
| ROE (annualised) | -5.0% | -23.3% | Strengthening |
| HY21 share of FY21 revenue | 29.7% | — | Other half was 70.3% |
| HY21 share of FY21 NPAT | 52.6% | — | Other half was 47.4% |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.
Source-backed analysis from the filing set attached to this briefing.